About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

An Evolution in Name, Structure, and Strategy Reflecting the Company’s AI-Driven Platform and Bio-Native Discovery Vision

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announced a unification under a single corporate brand, MindWalk, and a change of its Nasdaq ticker symbol to HYFT. The new identity conveys the Company’s evolution into a Bio-Native AI platform business built at the intersection of AI, multi-omics data, and advanced laboratory research.

“Today is an evolutionary step forward,” said Dr. Jennifer Bath, President and Chief Executive Officer of MindWalk. “Inspired by Darwin’s thinking path, MindWalk is about seeing what others can’t—patterns hidden in biology that point to better medicines. Our role is to convert that insight into impact, uniting science, computation, and responsible experimentation to change the pace of care.”

MindWalk: A New Era in Bio-Native AI-Powered Discovery

Inspired by Charles Darwin’s daily walks along his “thinking path” — where he questioned convention and advanced new theories — MindWalk carries that spirit forward. It represents a modern extension of that philosophy: a transformative, pattern-seeking journey through the complexity of biology, powered by the combined strengths of AI, data and advanced lab research.

Now operating as a Bio-Native AI company, MindWalk reimagines discovery by intelligently integrating data across formats and disciplines—turning information into dynamic biological meaning. By making biological diversity computable, MindWalk unifies this data into a single, structured system that accelerates discovery with depth and direction.

At the core of this transformation is the Company’s LensAI™ platform powered by HYFT® technology, built to redefine how biologics are discovered and developed. Drug discovery, unified—from idea to impact. This brand evolution is also a business transformation. MindWalk is expanding beyond specialized wet-lab services to commercialize an intelligence-platform modelamplifying discovery, enabling recurring SaaS offerings, creating generative asset opportunities, and supporting scalable partnerships across the pharmaceutical ecosystem.

Key Business Highlights:

  • Unified Brand Identity: ImmunoPrecise Antibodies (IPA) together with its subsidiaries BioStrand and Talem are now unified as MindWalk, a single brand under the umbrella of MindWalk Holdings Corp.
  • Business Model Shift: Transitioning from standalone wet-lab services to an integrated, scalable platform company model — launching DaaS, SaaS offerings, enhancing asset generation, and enabling large-scale partnerships
  • New Nasdaq Ticker: “HYFT” — replacing “IPA” to reflect the foundational role of HYFT® technology in the company’s AI stack

“MindWalk is the first to make biological diversity truly computable — integrating multi-modal data into a structured system that drives insight with clarity, speed, and depth,” added Dr. Bath.

For more information visit: mindwalkAI.com

About MindWalk

MindWalk is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT® technology and the LensAI™ platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable United States and Canadian securities laws. Forward-looking statements are often identified by words such as “expects,” “intends,” “plans,” “anticipates,” “believes,” “potential,�� or similar expressions, or by statements that certain actions, events, or results “may,” “will,” “could,” or “might” occur or be achieved. These include, but are not limited to, statements regarding the Company’s name change and ticker symbol transition to “HYFT,” the anticipated benefits of rebranding under the MindWalk AI identity, projected scalability and adoption of the HYFT® technology and LenAI™ platform, and the Company’s strategic shift toward a unified, AI-native discovery model.

Forward-looking statements are based on management’s current expectations, assumptions, and projections about future events and Company performance. Actual results could differ materially from those expressed or implied due to factors beyond the Company’s control, including: operational challenges in executing the rebrand and technology consolidation; risks associated with platform scalability and AI integration; scientific or technical validation hurdles; evolving market adoption dynamics in the SaaS and biologics R&D sectors; economic, geopolitical, or regulatory shifts; and customer or partner response to the new corporate structure.

Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied herein. Additional information about these and other risks and uncertainties is set out in the Company’s Annual Report on Form 20-F, as amended, for the fiscal year ended April 30, 2025, available on the Company’s SEDAR+ profile at www.sedarplus.ca and EDGAR profile at www.sec.gov/edgar. If any of these risks materialize, the Company’s actual results, performance, or achievements could vary significantly from those currently anticipated.

Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements to reflect new information, future events, or otherwise.

"Today is an evolutionary step forward,” said Dr. Jennifer Bath, President and Chief Executive Officer of MindWalk. “Inspired by Darwin’s thinking path, MindWalk is about seeing what others can’t—patterns hidden in biology that point to better medicines."

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.